S

Salarius Pharmaceuticals
D

SLRX

1.37000
USD
-0.07
(-4.86%)
Market Closed
Volume
348
EPS
-214
Div Yield
-
P/E
-0
Market Cap
1,974,385
OverviewSignalsIdeasNews
Related Instruments
    ABBV
    ABBV
    -4.630
    (-2.73%)
    176.95 USD
    B
    BHC
    -0.27000
    (-3.08%)
    8.48500 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    155.14 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    99.16 USD
    O
    OPK
    0.01500
    (0.92%)
    1.64500 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.63 USD
    P
    PSTV
    -0.08000
    (-6.35%)
    1.18000 USD
    Z
    ZYME
    -0.873
    (-5.37%)
    15.380 USD
    More
News

Title: Salarius Pharmaceuticals Inc.

Sector: Healthcare
Industry: Biotechnology
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.